Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
Gainers
Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results.
United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday
U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points. Here is the list of some big stocks recording gains in the previous session.
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results.
Where Arcturus Therapeutics Stands With Analysts
Arcturus Therapeutics (NASDAQ:ARCT) has observed the following analyst ratings within the last quarter:
Cantor Fitzgerald Maintains Overweight on Arcturus Therapeutics, Raises Price Target to $44
Cantor Fitzgerald analyst Pete Stavropoulos maintains Arcturus Therapeutics (NASDAQ:ARCT) with a Overweight and raises the price target from $39 to $44.
Why Rogers Shares Are Trading Sharply Lower; Here Are 33 Stocks Moving Premarket
Gainers
Avinger, Inc. (NASDAQ: AVGR) rose 32% to $1.36 in pre-market trading. Avinger is expected to release its financial results for the third quarter on Wednesday, November 9, 2022.
Match Group, Super Micro Computer And Some Other Big Stocks Moving Higher In Today’s Pre-Market Session
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Reported Late Tuesday, Arcturus Announces Collaboration With CSL To Develop And Commercialize Self-Amplifying mRNA Vaccines; Arcturus To Receive Upfront Payment Of $200M And More Than $4B In Potential Development And Commercial Milestones
Arcturus to receive upfront payment of $200 million and more than $4 billion in potential development and commercial milestones
40% profit sharing for COVID-19 vaccines, up to double digit
BARDA Backs Arcturus’ Influenza Vaccine Program
Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) received an award for up to $63.2 million from the Biomedical Advanced Research and Development Authority…
Arcturus’ COVID-19 Booster Shows Durability Against Omicron Variants
Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) announced updated data from its ongoing ARCT-154 booster clinical trial. The new results demonstrate a broad…